Where the Street stands
These are third-party analyst opinions from named firms, not advice, and not a prediction. How we score this
29 firms currently rating it, weighted by track record.
The 27 firms with a track record here beat the S&P 41% of the time over 12 months.
Pro: see the crowd-vs-sharp split for ORCLAnalysts rate Oracle a consensus buy with an average price target of $248.15, implying 107% upside from current levels; 37 of 41 analysts are bullish while one rates sell. Most recent action came from CLSA, which initiated coverage at hold on July 20, though earlier in June multiple firms maintained outperform and buy ratings, with Wedbush among those backing the stock. Oracle reported 20.6% revenue growth and 21.9% EPS growth year-over-year with a 25.4% net margin, though the stock carries a high debt-to-equity ratio of 3.89 and trades at 11.01x forward earnings. The stock gained 4.27% today amid broader tech sector volatility tied to China AI concerns.
Generated from the data on this page; may contain errors. Analyst opinions belong to the named firms. Informational only, not investment advice.
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 20, 2026 | CLSA | ● Initiated | |
| Jun 11, 2026 | Bernstein | ○ Maintained |
Create a free account to unlock all analyst ratings, key stats, and news. No credit card, takes 30 seconds.
Sign up free